Our pioneering SomaScan® Assay is a game changer for your oncology research

Accelerate your biomarker discovery with sensitive detection of 7,000 proteins from a 55-μL sample

The SomaScan Assay is designed for sensitivity and specificity to detect low-abundant proteins, such as cytokines, to lead to your next breakthrough discovery.

The SomaScan Assay Empowers Discovery

Diagnostic

Identify unique cancer-specific protein biomarkers for future diagnostic indicators

Prognostic

Monitor proteins over time for markers indicative of disease progression/regression

Predictive

Reveal proteins that correlate with a cancer event for development of preventive measures

Stratification

Define protein signatures that correlate with specific subtypes, for use in therapeutic development

Also available: SomaScan Panels for targeted data:
Oncology
863 analytes
Cytokines
168 analytes

SomaScan Assay Tech Note

Oncology White Paper

Whitepaper-image_Mockkup_thumbnail

Oncology Publications

Publications-Thumbnail_v3@2x

Oncology Proteomics Webinar

Request information On The SomaScan Assay